Back to Search
Start Over
Knockdown of Muscle-Specific Ribosomal Protein L3-Like Enhances Muscle Function in Healthy and Dystrophic Mice
- Source :
- Nucleic Acid Therapeutics. 31:457-464
- Publication Year :
- 2021
- Publisher :
- Mary Ann Liebert Inc, 2021.
-
Abstract
- Ribosomal protein L3-like (RPL3L) is a poorly characterized ribosomal protein that is exclusively expressed in skeletal and cardiac muscle. RPL3L is also downregulated in Duchenne muscular dystrophy (DMD), suggesting that it may play an important role in muscle biology. In this study, we investigated the role of RPL3L in skeletal muscle of healthy C57 and dystrophic mdx mice. We show that RPL3L is developmentally regulated and that intramuscular adeno-associated virus (AAV)-mediated RPL3L knockdown in the tibialis anterior of C57 and mdx mice results in increased specific force with improved resistance to eccentric contraction induced muscle damage in dystrophic muscles. The mechanism by which RPL3L knockdown improves muscle function remains unclear. Histological observations showed a significant increase in muscle length and decrease in muscle cross-sectional area after RPL3L inhibition suggesting that this ribosomal protein may play a role in myofiber morphology. The endogenous downregulation of RPL3L in DMD may be a protective mechanism that attempts to improve skeletal muscle function and counteract the dystrophic phenotype.
- Subjects :
- 0301 basic medicine
Ribosomal Protein L3
Duchenne muscular dystrophy
Endogeny
Biology
Biochemistry
Dystrophin
Mice
03 medical and health sciences
0302 clinical medicine
Downregulation and upregulation
Ribosomal protein
Drug Discovery
Genetics
medicine
Animals
Myocyte
Muscle, Skeletal
Molecular Biology
Gene knockdown
Cardiac muscle
Skeletal muscle
medicine.disease
Cell biology
Muscular Dystrophy, Duchenne
Disease Models, Animal
030104 developmental biology
medicine.anatomical_structure
030220 oncology & carcinogenesis
Mice, Inbred mdx
Molecular Medicine
Muscle Contraction
Subjects
Details
- ISSN :
- 21593345 and 21593337
- Volume :
- 31
- Database :
- OpenAIRE
- Journal :
- Nucleic Acid Therapeutics
- Accession number :
- edsair.doi.dedup.....92aff6265f1051b2b1c39cba2aba69a4